NEU 3.32% $20.52 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-1215

  1. 853 Posts.
    lightbulb Created with Sketch. 278
    I think your last comment is fair, to a degree. It is pedantic and I probably did not need to comment and in hindsight, wish I didn't. It doesn't add to the discussion and has already been covered ad nauseam but this issue is a trigger for me for some reason.

    I do want to ask though about the reference to "interpretation of the agreement known publicly" - are you suggesting that I shouldn't make this view public? I don't ask in an incredulous sense, I genuinely am interested and wonder whether you think it is detrimental/negative for me to provide this opinion publicly?

    I have always respected your contributions so am interested in your view.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.